We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+19.19%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$783M
AUM Growth
+$36.9M
Cap. Flow
-$49.7M
Cap. Flow %
-6.35%
Top 10 Hldgs %
34.67%
Holding
106
New
16
Increased
38
Reduced
39
Closed
13

Top Buys

Rank Stock Value
1
TFX icon
Teleflex
TFX
+$22.4M
2
KROS icon
Keros Therapeutics
KROS
+$11M
3
SYK icon
Stryker
SYK
+$9.66M
4
RCUS icon
Arcus Biosciences
RCUS
+$9.62M
5
DGX icon
Quest Diagnostics
DGX
+$8.21M

Top Sells

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$16M
2
ELV icon
Elevance Health
ELV
+$15M
3
HUM icon
Humana
HUM
+$11.2M
4
COR icon
Cencora
COR
+$8.56M
5
THC icon
Tenet Healthcare
THC
+$8.34M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
101
PUT
Merck
MRK
$328B
– –
-100,000
Closed -$12.4M
QTRX icon
102
Quanterix
QTRX
$139M
– –
-176,377
Closed -$2.33M
TELA icon
103
TELA Bio
TELA
$32.3M
– –
-97,816
Closed -$460K
VKTX icon
104
Viking Therapeutics
VKTX
$3.97B
– –
-20,372
Closed -$1.08M
VTYX
105
DELISTED
Ventyx Biosciences
VTYX
– –
-1,160,022
Closed -$2.68M
AUGX
106
DELISTED
Augmedix, Inc. Common Stock
AUGX
– –
-566,845
Closed -$499K
1 2 3 4
5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Parkman Healthcare Partners held 106 positions worth $783M, up 4.9% from $747M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parkman Healthcare Partners withdrew a net $49.7M in Q3 2024, closing 13 positions and reducing 39 holdings. Its most notable exit was Elevance Health, an estimated $15M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 98% a quarter earlier, followed by Industrials.

Against the trend, Parkman Healthcare Partners opened a new position in Teleflex worth $23.8M.

  • Parkman Healthcare Partners's largest Q3 2024 buy was Teleflex: 96,144 shares worth $23.8M.
  • Parkman Healthcare Partners added most to Keros Therapeutics in Q3 2024, an estimated $11M increase.
  • Parkman Healthcare Partners's biggest Q3 2024 reduction was United Therapeutics, cutting an estimated $16M.
  • Parkman Healthcare Partners fully exited Elevance Health in Q3 2024, selling an estimated $15M.
  • Parkman Healthcare Partners's ten largest holdings make up 35% of its $783M portfolio in Q3 2024.
  • Parkman Healthcare Partners opened 16 new positions and closed 13 in Q3 2024.
  • Parkman Healthcare Partners's portfolio value rose 4.9% quarter-over-quarter to $783M.

Based on Parkman Healthcare Partners's 13F filing for Q3 2024, filed 14 Nov 2024.